JJ builds case for Talvey FDA panel questions PD-1 drugs for certain cancers

ENTA Stock  USD 7.14  0.36  4.80%   
About 62% of Enanta Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Enanta Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Enanta Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Enanta Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
New data show Talveys potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinsons drug data and Biogen ended a Sage collaboration.

Read at finance.yahoo.com
Yahoo News
  

Enanta Pharmaceuticals Fundamental Analysis

We analyze Enanta Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enanta Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enanta Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Enanta Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Enanta Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enanta Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Enanta Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Enanta Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Enanta Pharmaceuticals Related Equities

LYELLyell Immunopharma   5.17   
0%
100.0%
KRONKronos Bio   5.15   
0%
99.0%
DSGNDesign Therapeutics   2.77   
0%
53.0%
IPSCCentury Therapeutics   2.67   
0%
51.0%
INBXInhibrx   1.90   
0%
36.0%
GLUEMonte Rosa   0.89   
0%
17.0%
STOKStoke Therapeutics   0.47   
0%
9.0%
MLYSMineralys Therapeutics,   0.39   
0%
7.0%
CRNXCrinetics Pharmaceuticals   0.14   
2.0%
0%
MRUSMerus BV   0.25   
4.0%
0%
CCCCC4 Therapeutics   0.63   
12.0%
0%
CGEMCullinan Oncology   0.63   
12.0%
0%
HOWLWerewolf Therapeutics   1.32   
25.0%
0%
RVMDRevolution Medicines   1.57   
30.0%
0%
EWTXEdgewise Therapeutics   2.42   
46.0%
0%
IKNAIkena Oncology   2.61   
50.0%
0%

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bonds Directory
Find actively traded corporate debentures issued by US companies